Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30345906

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Nov 29
First author
Schmid P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Jan;9(1):OF5. doi: 10.1158/2159-8290.CD-NB2018-154.
    note
    Source null
    related pmid
    30464002
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Mar 7;380(10):985-986. doi: 10.1056/NEJMc1900150.
    note
    Source null
    related pmid
    30855754
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Mar 7;380(10):986. doi: 10.1056/NEJMc1900150.
    note
    Source null
    related pmid
    30855755
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Mar 7;380(10):986-987. doi: 10.1056/NEJMc1900150.
    note
    Source null
    related pmid
    30855756
    relationship
    Comment in

Authors and identifiers

  1. name
    Schmid P
    type
    Author
  2. name
    Adams S
    type
    Author
  3. name
    Rugo HS
    type
    Author
  4. name
    Schneeweiss A
    type
    Author
  5. name
    Barrios CH
    type
    Author
  6. name
    Iwata H
    type
    Author
  7. name
    Diéras V
    type
    Author
  8. name
    Hegg R
    type
    Author
  9. name
    Im SA
    type
    Author
  10. name
    Shaw Wright G
    type
    Author
  11. name
    Henschel V
    type
    Author
  12. name
    Molinero L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Schmid P
    type
    Author
  2. name
    Adams S
    type
    Author
  3. name
    Rugo HS
    type
    Author
  4. name
    Schneeweiss A
    type
    Author
  5. name
    Barrios CH
    type
    Author
  6. name
    Iwata H
    type
    Author
  7. name
    Diéras V
    type
    Author
  8. name
    Hegg R
    type
    Author
  9. name
    Im SA
    type
    Author
  10. name
    Shaw Wright G
    type
    Author
  11. name
    Henschel V
    type
    Author
  12. name
    Molinero L
    type
    Author
bibliography ids
  1. nci-bib-3262ba023d78d62e5af56e06
book metadata
content sha256
6c141523d714a5ccf6aca07f52287caa28152e68dbdd24bcc64f68c3792808a9
document type
citation
dois
  1. 10.1056/NEJMoa1809615
electronic publication date
display
2018 Oct 20
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30345906
immutable id
pubmed:30345906@6c141523d714a5ccf6aca07f52287caa28152e68dbdd24bcc64f68c3792808a9
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
22
name
The New England journal of medicine
nlm unique id
0255562
pages
2108-2121
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Jan;9(1):OF5. doi: 10.1158/2159-8290.CD-NB2018-154.
    note
    Source null
    related pmid
    30464002
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Mar 7;380(10):985-986. doi: 10.1056/NEJMc1900150.
    note
    Source null
    related pmid
    30855754
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Mar 7;380(10):986. doi: 10.1056/NEJMc1900150.
    note
    Source null
    related pmid
    30855755
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Mar 7;380(10):986-987. doi: 10.1056/NEJMc1900150.
    note
    Source null
    related pmid
    30855756
    relationship
    Comment in
outcomes validated
false
pmid
30345906
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
b9dfaf8608bdf06233f5b792ad2bbd8c4bc82b18154cd28b66d8983a8b1ee40b
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Nov 29
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30345906/
title
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Preserved source evidence · Not medical advice